3D BioLabs LLC (“3D BioLabs” or “3DB”), has reached a pivotal milestone in the field of regenerative medicine as recently published in the Proceedings of the National Academy of Sciences. 3DB’s study has demonstrated a new approach to creating large organs to solve the organ transplant shortage.
